JP Patent

JP7224337B2 — ３－フルオロ－４－［７－メトキシ－３－メチル－８－（１－メチル－１Ｈ－ピラゾール－４－イル）－２－オキソ－２，３－ジヒドロ－イミダゾ［４，５－ｃ］キノリン－１－イル］－ベンゾニトリル含む医薬製剤

Assigned to Merck Patent GmbH · Expires 2023-02-17 · 3y expired

What this patent protects

Patent listed against paltusotine-hydrochloride.

Drugs covered by this patent

paltusotine-hydrochloride (PALTUSOTINE HYDROCHLORIDE)

Patent Metadata

Patent number: JP7224337B2
Jurisdiction: JP
Classification: —
Expires: 2023-02-17
Drug substance claim: No
Drug product claim: No
Assignee: Merck Patent GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.